Enara Bio

Series-B
enarabio.com Biotech & Healthcare Oxford, United Kingdom
Total Funding $32.5M
Latest Round Undisclosed Series-B
Last Announced Jun 2, 2026
Investors 6 Backers
Decision Makers Profile Active

About Enara Bio

Develops cancer immunotherapies targeting unconventional antigens

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B
Global Headquarters Oxford, United Kingdom
Tracked Since Nov 6, 2026

Web & Domain Identity

Official Website enarabio.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @Enara_Bio (304 followers)
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised undisclosed · Series-B

    fundraisingfox.com

  2. Capital Raise

    Raised $32,500,000 · Series-B

    news.google.com

Investors & Backers

6
M Ventures
Pfizer Venture Investments
RA Capital Management
Samsara Biocapital
SV Health Investors
The Francis Crick Institute

Funding History

2 Rounds
Series-B equity · Jun 2, 2026
Series-B equity · Oct 3, 2024
$32,500,000 news.google.com

Founders & Leadership

8

Andrew Fadden

Chief Business Officer

Work email & phone locked Unlock →

Drew Pardoll

Co-founder of Enara Bio

Work email & phone locked Unlock →

George Kassiotis

Co-founder of Enara Bio

Work email & phone locked Unlock →

Houman Ashrafian

Co-founder of Enara Bio

Work email & phone locked Unlock →

Kevin Pojasek

President and CEO

Work email & phone locked Unlock →

Scott Drutman

Chief Medical Officer

Work email & phone locked Unlock →

Scott Druttman

Chief Medical Officer

Work email & phone locked Unlock →

Stacey Davis

Chief Financial Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts